Visalytics
Visalytics
approved EB-2 (NIW)

Visiting Associate

Chemical Engineering · India · 2025-01-15

Processing Time
81 days
Decision Date
2025-01-15
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue developing advanced mathematical and computational models to predict the efficacy and safety of medical products. His work utilizes custom computer scripts and proprietary pharmacological software to simulate complex physiological processes. These simulations are intended to guide drug policy, support regulatory decisions, and inform effective dosage strategies to enhance patient safety.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical public health challenges like the opioid crisis and informs U.S. medical regulations.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D. and high citation metrics (top 1% in field) demonstrate his capability to lead this research.

3 Waiver Benefit Met

The national benefit of improving drug safety and regulatory efficiency outweighs the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in Chemical and Biochemical Engineering and his record of 13 peer-reviewed journal articles and 7 conference abstracts. His research has garnered 132 citations, with several papers ranking in the top 1% and 10% of most-cited publications in his field. These metrics demonstrated that he met all three Dhanasar prongs by showing the national importance of his work and his strong position to advance it.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Original Contributions

Similar Cases

Others

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Illinois 40 days 2025-03-24
The petitioner proposes to design novel PK/PD models to determine the efficacy and safety of new drugs using clinical data and computational drug modeling. This work focuses on reducing toxicity, optimizing dosage, and increasing the success rate of drug approvals to make therapies safer and more accessible.
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
Maryland 42 days 2025-01-10
The petitioner proposes to continue his research in the field of public health, specifically focusing on pharmaceutical science to address global healthcare challenges. His work aims to mitigate resource shortages and reduce the burden of adverse drug reactions through computational science and engineering methodologies. The intended impact is to advance global healthcare outcomes and improve the safety and efficiency of the healthcare system.
View Case

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Illinois 110 days 2023-02-02
The petitioner proposes to conduct research combining pharmacoepidemiology, pharmacoeconomics, and health outcomes science to identify treatment risks and prescribing patterns. Her work focuses on uncovering disease mechanisms and patient outcomes in chronic conditions like COPD, liver disease, and breast cancer to inform better diagnostic and therapeutic strategies. The endeavor aims to improve healthcare delivery efficiency and public health innovation within the United States.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Engineering cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-15.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 81 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist